Outcomes of CAR T-cell therapy in high-grade B-cell lymphomas compared to DLBCL: a weighted comparison analysis

Abstract: High-grade B-cell lymphomas (HGBL, including double-hit/triple-hit [HGBL-DH/TH], and HGBL not otherwise specified) have a poor prognosis upon failure of first-line therapy. Anti-CD19 chimeric antigen receptor (CAR) T-cell therapy for third-line aggressive large B-cell lymphomas (LBCL) resu...

Descrición completa

Detalles Bibliográficos

Principais autores:	Anna Dodero, Giusy Ceparano, Beatrice Casadei, Piera Angelillo, Stefania Bramanti, Maria Chiara Tisi, Silva Ljevar, Federico Stella, Annalisa Chiappella, Barbara Botto, Ilaria Cutini, Giada Zanirato, Patrizia Chiusolo, Anna Maria Barbui, Mirko Farina, Alice Di Rocco, Giovanni Grillo, Jacopo Olivieri, Mauro Krampera, Marco Ladetto, Anna Guidetti, Pier Luigi Zinzani, Cristiana Carniti, Paolo Corradini
Formato:	Artigo
Idioma:	Inglês
Publicado:	Elsevier 2025-12-01
Series:	Blood Advances
Acceso en liña:	http://www.sciencedirect.com/science/article/pii/S2473952925004690
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!